| Literature DB >> 35887279 |
Ahmed T El-Serafi1,2, Ibrahim El-Serafi2,3, Ingrid Steinvall1,2, Folke Sjöberg1,2, Moustafa Elmasry1,2.
Abstract
Cell regenerative therapy is a modern solution for difficult-to-heal wounds. Keratinocytes, the most common cell type in the skin, are difficult to obtain without the creation of another wound. Stem cell differentiation towards keratinocytes is a challenging process, and it is difficult to reproduce in chemically defined media. Nevertheless, a co-culture of keratinocytes with stem cells usually achieves efficient differentiation. This systematic review aims to identify the secretions of normal human keratinocytes reported in the literature and correlate them with the differentiation process. An online search revealed 338 references, of which 100 met the selection criteria. A total of 80 different keratinocyte secretions were reported, which can be grouped mainly into cytokines, growth factors, and antimicrobial peptides. The growth-factor group mostly affects stem cell differentiation into keratinocytes, especially epidermal growth factor and members of the transforming growth factor family. Nevertheless, the reported secretions reflected the nature of the involved studies, as most of them focused on keratinocyte interaction with inflammation. This review highlights the secretory function of keratinocytes, as well as the need for intense investigation to characterize these secretions and evaluate their regenerative capacities.Entities:
Keywords: growth factor; inflammatory mediator; keratinocyte; keratinocyte secretion; skin regeneration; stem cell differentiation
Mesh:
Year: 2022 PMID: 35887279 PMCID: PMC9323141 DOI: 10.3390/ijms23147934
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Flow chart of the online search strategy used in this study.
Figure 2Stratification of the retrieved articles (338) into relevant (100) and irrelevant (238) references. The relevant references were further divided according to the study cell-type, while the irrelevant studies were divided according to the reason for rejection.
Figure 3The reported present (A) and absent (B) secretions were mainly cytokines (75% and 75%, respectively), growth factors (6% and 17%, respectively), and antimicrobial peptides (5% and 8%, respectively).
The frequency of the reported presence or absence of secretions in cell culture supernatant.
| n | Cell Secretion | Frequency | Frequency | n | Cell Secretion | Frequency | Frequency |
|---|---|---|---|---|---|---|---|
|
| IL-8 | 39 |
| CXCL16 | 1 | ||
|
| IL-6 | 15 | 1 |
| HSP70 | 1 | |
|
| TNF | 15 | 3 |
| Human β-defensin 1 | 1 | |
|
| IL-1a | 12 |
| IL-1 receptor | 1 | ||
|
| Interferon inducible protein 10 (CXCL10) | 9 |
| IL-15 | 1 | ||
|
| IL-1β | 7 | 2 |
| IL-2 | 1 | |
|
| RANTES (CCL5) | 5 |
| IL-20 | 1 | ||
|
| Human β-defensin 2 | 5 | 1 |
| IL-23 | 1 | |
|
| IL-12 | 5 |
| IL-7 | 1 | ||
|
| CCL-20 | 4 |
| IL-10 | 1 | ||
|
| CXCL1 (GRO-a) | 4 |
| IL-18 | 1 | ||
|
| Glutamate | 3 |
| IL-19 | 1 | ||
|
| CCL2/MCP1 | 3 |
| IL-20 | 1 | ||
|
| FGF2 | 3 | 1 |
| Fas ligand | 1 | |
|
| Hyaluronan | 3 |
| Granulocyte colony stimulating factor | 1 | ||
|
| Interferon γ | 3 |
| Haptoglobin | 1 | ||
|
| IL-4 | 3 |
| IL-23p40 | 1 | ||
|
| IL-10 | 3 |
| IL-3 | 1 | ||
|
| IL-36γ | 3 |
| Keratin 17 | 1 | ||
|
| LL37 | 3 |
| Kallikrein-related peptidase | 1 | ||
|
| Macrophage derived chemokine (CCL22) | 3 |
| Lympho–epithelial Kazal-type inhibitor | 1 | ||
|
| Prostaglandin E2 | 3 |
| Macrophage inflammatory protein (MIP)-1b | 1 | ||
|
| VEGF | 3 |
| Macrophage inflammatory protein (MIP)-2 | 1 | ||
|
| EGF | 2 |
| Macrophage migration inhibitory factor | 1 | ||
|
| GM-CSF | 2 |
| miR-203 | 1 | ||
|
| Human β-defensin 3 | 2 |
| miR-675 | 1 | ||
|
| IL-1ra | 2 |
| miR-3196 | 1 | ||
|
| MMP1 | 2 |
| MMP10 | 1 | ||
|
| MMP2 | 2 |
| Nerve growth factor | 1 | ||
|
| MMP9 | 2 |
| Nitric Oxide | 1 | ||
|
| S100 | 2 |
| Serpin E1 | 1 | ||
|
| TGF-ß | 2 |
| Sphingosine 1 phosphate | 1 | 1 | |
|
| Thymic stromal lymphopoietin | 2 | 1 |
| CCL17 | 1 | |
|
| Adenylate kinase | 1 |
| Stem cell factor | 1 | ||
|
| α-Melanocyte stimulating hormone | 1 |
| TGF-α | 1 | ||
|
| Artemin | 1 |
| Tissue inhibitor of metalloproteinases 2 | 1 | ||
|
| β-endorphin | 1 |
| VEGF-EG | 1 | ||
|
| Corticotropin-releasing hormone | 1 |
| p19/EBI3 heterodimeric cytokine complex | 1 | ||
|
| CXCL11 | 1 |
| IL-37 | 1 | ||
|
| CXCL12 | 1 |
| PDGF | 1 |
Figure 4Clustering of the studied proteins shows three distinct clusters, with the growth factors on the border between the first and second clusters.
The frequency of reported secretions in cell culture supernatant, according to the cell-type.
| n | Cell Secretion | HaCaT | Primary Keratinocytes | Other Cell-Types | Total |
|---|---|---|---|---|---|
|
| IL-8 | 19 | 18 | 2 | 39 |
|
| IL-6 | 10 | 4 | 1 | 15 |
|
| TNF | 6 | 8 | 1 | 15 |
|
| IL-1a | 3 | 8 | 1 | 12 |
|
| CXCL10 | 2 | 7 | 0 | 9 |
|
| IL-1β | 4 | 3 | 0 | 7 |
|
| human β-defensin 2 | 1 | 4 | 0 | 5 |
|
| IL-12 | 2 | 2 | 1 | 5 |
|
| RANTES (CCL5) | 2 | 3 | 0 | 5 |
|
| CCL-20 | 1 | 3 | 0 | 4 |
|
| CXCL1 (GRO-a) | 3 | 1 | 0 | 4 |
|
| CCL2 /MCP1 | 1 | 2 | 0 | 3 |
|
| CCL22 | 1 | 2 | 0 | 3 |
|
| FGF2 | 2 | 1 | 0 | 3 |
|
| Glutamate | 1 | 2 | 0 | 3 |
|
| Hyaluronan | 2 | 1 | 0 | 3 |
|
| IFNγ | 0 | 2 | 1 | 3 |
|
| IL-4 | 2 | 1 | 0 | 3 |
|
| IL-36γ | 0 | 3 | 0 | 3 |
|
| LL37 | 0 | 3 | 0 | 3 |
|
| Prostaglandin E2 | 1 | 2 | 0 | 3 |
|
| VEGF | 1 | 1 | 1 | 3 |
|
| EGF | 1 | 0 | 1 | 2 |
|
| GM-CSF | 1 | 0 | 1 | 2 |
|
| IL-1ra | 0 | 2 | 0 | 2 |
|
| MMP1 | 1 | 1 | 0 | 2 |
|
| MMP2 | 1 | 1 | 0 | 2 |
|
| MMP9 | 1 | 1 | 0 | 2 |
|
| TGF-ß | 1 | 1 | 0 | 2 |